SCHEMBL133683

SCHEMBL133683

CC(=O)CCN1C(=O)c2ccccc2C1=O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.59
PKM P14618 1/20 0.57
ALDH1A1 P00352 4/20 0.57
HPGD P15428 2/20 0.57
GAA P10253 1/20 0.57
HSD17B10 Q99714 1/20 0.57
POLB P06746 1/20 0.55
MEN1 O00255 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.54
TSHR P16473 1/20 0.54
TP53 P04637 1/20 0.54
CA12 O43570 1/20 0.53
CA9 Q16790 1/20 0.53
GLS O94925 1/20 0.53
HDAC8 Q9BY41 3/20 0.53
HDAC3 O15379 2/20 0.53
HDAC4 P56524 2/20 0.53
HDAC1 Q13547 2/20 0.53
HDAC7 Q8WUI4 2/20 0.53
HDAC2 Q92769 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10671178 0.90 KMT2A (0.54) KMT2APKMALDH1A1HPGDGAA
SCHEMBL2084857 0.89 ALDH1A1 (0.59) KMT2AALDH1A1HSD17B10MEN1HDAC8
SCHEMBL29740524 0.89 ALDH1A1 (0.59) KMT2AALDH1A1HSD17B10MEN1HDAC8
SCHEMBL7443883 0.87 HDAC8 (0.65) KMT2AALDH1A1HPGDHSD17B10MEN1
SCHEMBL10495286 0.86 HDAC8 (0.68) KMT2AALDH1A1HPGDGAAMEN1
SCHEMBL10913404 0.86 HDAC8 (0.68) KMT2AALDH1A1HPGDGAAMEN1
Ethylene SCHEMBL9101813 0.86 ALDH1A1 (0.56) KMT2AALDH1A1HSD17B10MEN1HDAC8
Ethylene Glycol SCHEMBL7141967 0.84 ALDH1A1 (0.55) KMT2AALDH1A1HPGDHSD17B10MEN1
SCHEMBL10018578 0.84 MEN1 (0.66) KMT2AALDH1A1HPGDGAAHSD17B10
SCHEMBL14594063 0.84 KMT2A (0.60) KMT2AALDH1A1HPGDGAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3521289-B1 MNK INHIBITORS AND METHODS RELATED THERETO EFFECTOR THERAPEUTICS INC (US) 2023-10-25 EP disclosed
WO-2022032144-A1 SUBSTRATE ADAPTOR INHIBITORS OF PRMT5 AND USES THEREOF THE BROAD INSTITUTE, INC. (US) 2022-02-10 WO disclosed
US-20210338673-A1 MNK INHIBITORS AND METHODS RELATED THERETO EFFECTOR THERAPEUTICS INC (US) 2021-11-04 US disclosed
US-11044931-B2 Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof BASF SE (DE) 2021-06-29 US disclosed
US-11044931-B2 Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof BASF SE (DE) 2021-06-29 US disclosed
EP-2758041-B1 LOW-MOLECULAR MODULATORS OF THE COLD-MENTHOL RECEPTOR TRPM8 AND USE OF SAME BASF SE (DE) 2021-01-13 EP disclosed
CN-107635992-B Tricyclic heterocyclic compounds useful as TNF inhibitors 百时美施贵宝公司 2020-05-22 CN disclosed
EP-3271361-B1 TRICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF TNF BRISTOL MYERS SQUIBB CO (US) 2020-04-22 EP disclosed
EP-3271361-B1 TRICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF TNF BRISTOL MYERS SQUIBB CO (US) 2020-04-22 EP disclosed
US-20190350239-A1 LOW MOLECULAR WEIGHT MODULATORS OF THE COLD MENTHOL RECEPTOR TRPM8 AND USE THEREOF BASF SE (DE) 2019-11-21 US disclosed
WO-1991010656-A1 THIAZOLE DERIVATIVES CEDONA PHARMACEUTICALS B.V. (NL) 1991-07-25 WO disclosed
EP-0415948-A1 PROCESS FOR PREPARING A SUBSTITUTED OR AN UNSUBSTITUTED 4(5)-($g(v)-AMINOALKYL)IMIDAZOLE CEDONA PHARMACEUTICALS B.V. (NL) 1991-03-13 EP disclosed
WO-1989010360-A1 PROCESS FOR PREPARING A SUBSTITUTED OR AN UNSUBSTITUTED 4(5)-(omega-AMINOALKYL)IMIDAZOLE CEDONA PHARMACEUTICALS B.V. (NL) 1989-11-02 WO disclosed
WO-1989005643-A1 HETEROCYCLIC-SUBSTITUTED QUINOLINE-CARBOXYLIC ACIDS PFIZER INC. (US) 1989-06-29 WO disclosed
EP-0321191-A2 Heterocyclic-substituted quinoline-carboxylic acids PFIZER INC. (US) 1989-06-21 EP disclosed
US-RE32868-E Antihyperlipidemic compositions RESEARCH CORPORATION (US) 1989-02-14 US disclosed
EP-0076035-B1 PYRAZOLO(3,4-B)PYRIDINE DERIVATIVES ICI AMERICAS INC. (US) 1985-12-11 EP disclosed
US-4395417-A Antihyperlipidemic compositions RESEARCH CORPORATION (US) 1983-07-26 US disclosed
EP-0076035-A1 Pyrazolo(3,4-b)pyridine derivatives ICI AMERICAS INC. (US) 1983-04-06 EP disclosed
US-4364948-A Pyrazolo[3,4-b]pyridine compounds ICI AMERICAS INC. (US) 1982-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11044931-B2 Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof TRPM8, TRPM7, TRPM2 KMT2A 1629/4885PKM 2714/4885ALDH1A1 3977/4885
US-20210338673-A1 MNK INHIBITORS AND METHODS RELATED THERETO TNNI3K, NIM1K, NEK9 KMT2A 767/4885PKM 383/4885ALDH1A1 4285/4885
US-20190350239-A1 LOW MOLECULAR WEIGHT MODULATORS OF THE COLD MENTHOL RECEPTOR TRPM8 AND USE THEREOF TRPM8, TRPM7, TRPM2 KMT2A 1629/4885PKM 2714/4885ALDH1A1 3977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.